The "4th Shanghai Lingang Biomedical Innovation and Development Forum 2024 Advanced Therapeutic Drug Research and Development Theme Forum" hosted by the Drug Toxicology Professional Committee of the Chinese Pharmacological Society, the Shanghai Pharmacological Society, and the Toxicology Professional Committee of the Shanghai Pharmacological Society was held in Shanghai from August 30 to September 1, 2024.

Liu Baofeng, General Manager of Shandong Xinbo Pharmaceutical Research Co., Ltd. (hereinafter referred to as "Shandong Xinbo"), gave a wonderful report on the theme of "Key considerations for preclinical safety evaluation of nucleic acid vaccines".

1.Meeting content

Report topic: Improving the quality of non clinical research on advanced therapeutic drugs to ensure the safety of clinical research promotion
Meeting time: August 30th to September 1st, 2024

Venue: Grand Hyatt Shanghai Lingang (288 Yunying Road, Fengxian District, Shanghai)

Meeting Agenda: Registration Date for the Conference (August 30th) Meeting Report (August 31st September 1st)

Meeting time: September 1, 2024  At 15:00, the 8th Chinese Pharmacological Society of the Communist Party of China (CPC) held the Party Member Meeting (Enlarged) and the Plenary Committee Meeting of the Branch Committee of the Drug Toxicology Professional Committee of the Chinese Pharmacological Society.

2、 Meeting registration

Scan the QR code to register for the conference